Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: May 30, 2023

Patent: 8,901,378

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 8,901,378
Title:Corn event TC1507 and methods for detection thereof
Abstract: The invention provides DNA compositions that relate to transgenic insect resistant maize plants. Also provided are assays for detecting the presence of the maize TC1507 event based on the DNA sequence of the recombinant construct inserted into the maize genome and the DNA sequences flanking the insertion site. Kits and conditions useful in conducting the assays are provided.
Inventor(s): Barbour; Eric (Johnston, IA), Bing; James Wayne (Ankeny, IA), Cardineau; Guy A. (Tempe, AZ), Cressman, Jr.; Robert F. (Wilmington, DE), Gupta; Manju (Carmel, IN), Locke; Mary E. Hartnett (Mickleton, NJ), Hondred; David (Ankeny, IA), Keaschall; Joseph W. (Clive, IA), Koziel; Michael G. (Raleigh, NC), Meyer; Terry EuClaire (Urbandale, IA), Moellenbeck; Daniel (Granger, IA), Narva; Kenneth Edwin (Carlsbad, CA), Nirunsuksiri; Wilas (Auburn, WA), Ritchie; Stephen W. (Omaha, NE), Rudert; Marjorie L. (Boone, IA), Sanders; Craig D. (Bear, DE), Shao; Aihua (Johnston, IA), Stelman; Steven Jeffrey (San Diego, CA), Stucker; David S. (Johnston, IA), Tagliani; Laura Ann (Zionsville, IN), Van Zante; William M. (Urbandale, IA)
Assignee: Pioneer Hi-Bred International, Inc. (Johnston, IA)
Application Number:12/914,271
Patent Claims:see list of patent claims

Details for Patent 8,901,378

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2023-05-02
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2023-05-02
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2023-05-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.